QT
AVXL icon

Quantamental Technologies’s Anavex Life Sciences AVXL Stock Holding History

Quantamental Technologies’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,534
Closed -$172K – 430
2022
Q4 		$172K Buy
+18,534
New +$198K 0.08% 381

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Quantamental Technologies's AVXL Position: Q1 2023 in Review

Quantamental Technologies sold out of Anavex Life Sciences (AVXL) in Q1 2023, closing a stake of 18,534 shares — an estimated $172K sold.

Quantamental Technologies first reported a position in AVXL in Q4 2022 and held it in 1 quarter. The position peaked at $172K in Q4 2022. 141 funds tracked by Wall St. Rank hold AVXL as of Q1 2023.

  • Quantamental Technologies reported no remaining Anavex Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Quantamental Technologies sold 18,534 Anavex Life Sciences shares in Q1 2023, an estimated $172K.
  • Quantamental Technologies first reported a position in Anavex Life Sciences in Q4 2022 and held it in 1 quarter.
  • Quantamental Technologies's Anavex Life Sciences position peaked at $172K in Q4 2022.
  • 141 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2023.

Based on Quantamental Technologies's 13F filing for Q1 2023, filed 15 May 2023.